Literature DB >> 11170992

Evidence of porcine endogenous retroviruses in porcine factor VIII and evaluation of transmission to recipients with hemophilia.

W Heneine1, W M Switzer, J M Soucie, B L Evatt, V Shanmugam, G V Rosales, A Matthews, P Sandstrom, T M Folks.   

Abstract

Since 1984, unheated porcine clotting factor VIII (Hyate:C) has been used to treat severe bleeding episodes in persons with hemophilia who have antibodies to human clotting factor. We document the presence of porcine endogenous retrovirus (PERV) in plasma samples of pigs and in clinical lots of Hyate:C. Both gag and pol PERV RNA sequences were detected by reverse-transcriptase (RT) polymerase chain reaction in 13 of 13 lots of Hyate:C tested. Among 10 of these lots, RT activity also was detected, which confirms the presence of retroviral particles. To assess the transmission of PERV to Hyate:C recipients, we tested serum specimens from 88 recipients of Hyate:C and 23 noninfused control subjects for anti-PERV antibodies by using a Western blot assay. None of the samples was positive. Our data document that PERV particles are a common contaminant of Hyate:C products and suggest that the risk of PERV transmission from these percutaneous exposures is very low.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170992     DOI: 10.1086/318540

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist.

Authors:  Masahiro Shinoda; Arno W Tilles; Go Wakabayashi; Atsushi Takayanagi; Hirohisa Harada; Hideaki Obara; Kazuhiro Suganuma; François Berthiaume; Motohide Shimazu; Nobuyoshi Shimizu; Masaki Kitajima; Ronald G Tompkins; Mehmet Toner; Martin L Yarmush
Journal:  Tissue Eng       Date:  2006-05

2.  Detection and characterization of porcine endogenous retrovirus in porcine plasma and porcine factor VIII.

Authors:  D M Takefman; S Wong; T Maudru; K Peden; C A Wilson
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

3.  Monitoring for presence of potentially xenotic viruses in recipients of pig islet xenotransplantation.

Authors:  O Garkavenko; M C Croxson; M Irgang; A Karlas; J Denner; R B Elliott
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

Review 4.  Infection barriers to successful xenotransplantation focusing on porcine endogenous retroviruses.

Authors:  Joachim Denner; Ralf R Tönjes
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

5.  Characterization of endogenous retroviruses in sheep.

Authors:  Nikolai Klymiuk; Mathias Müller; Gottfried Brem; Bernhard Aigner
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

6.  Mouse retrovirus mediates porcine endogenous retrovirus transmission into human cells in long-term human-porcine chimeric mice.

Authors:  Yong-Guang Yang; James C Wood; Ping Lan; Robert A Wilkinson; Megan Sykes; Jay A Fishman; Clive Patience
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

7.  Molecular and enzymatic characterization of the porcine endogenous retrovirus protease.

Authors:  Jürgen H Blusch; Sigrid Seelmeir; Klaus von der Helm
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Identification of receptors for pig endogenous retrovirus.

Authors:  Thomas A Ericsson; Yasuhiro Takeuchi; Christian Templin; Gary Quinn; Shelli F Farhadian; James C Wood; Beth A Oldmixon; Kristen M Suling; Jennifer K Ishii; Yoshinori Kitagawa; Takayuki Miyazawa; Daniel R Salomon; Robin A Weiss; Clive Patience
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-09       Impact factor: 11.205

9.  Identification of exogenous forms of human-tropic porcine endogenous retrovirus in miniature Swine.

Authors:  James C Wood; Gary Quinn; Kristen M Suling; Beth A Oldmixon; Brian A Van Tine; Robert Cina; Scott Arn; Christine A Huang; Linda Scobie; David E Onions; David H Sachs; Henk-Jan Schuurman; Jay A Fishman; Clive Patience
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 10.  Emerging trends in plasma-free manufacturing of recombinant protein therapeutics expressed in mammalian cells.

Authors:  Leopold Grillberger; Thomas R Kreil; Sonia Nasr; Manfred Reiter
Journal:  Biotechnol J       Date:  2009-02       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.